- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.20 Å
- Oligo State
- hetero-3-3-3-3-3-3-3-3-mer
- Ligands
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.2: 9 residues within 4Å:- Chain C: N.107, I.108
- Chain E: Y.50, F.114, T.115, F.117
- Chain F: W.88, D.89, T.94
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:Y.50, E:T.115
NAG-NAG-BMA-MAN.10: 5 residues within 4Å:- Chain C: N.355, S.357
- Ligands: NAG-NAG-BMA.9, NAG-NAG-BMA.9, NAG.46
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.13: 10 residues within 4Å:- Chain C: N.64, K.67, T.206, E.245, N.246
- Chain H: N.30, A.31, D.49, S.51, F.90
5 PLIP interactions:3 interactions with chain C, 2 interactions with chain H- Hydrophobic interactions: C:T.206
- Hydrogen bonds: C:N.64, C:K.67, H:D.49, H:S.51, H:S.51
NAG-NAG-BMA-MAN.16: 9 residues within 4Å:- Chain I: N.107, I.108
- Chain L: Y.50, F.114, T.115, F.117
- Chain M: W.88, D.89, T.94
2 PLIP interactions:2 interactions with chain L- Hydrogen bonds: L:Y.50, L:T.115
NAG-NAG-BMA-MAN.24: 5 residues within 4Å:- Chain I: N.355, S.357
- Ligands: NAG-NAG-BMA.23, NAG-NAG-BMA.23, NAG.49
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.27: 10 residues within 4Å:- Chain I: N.64, K.67, T.206, E.245, N.246
- Chain N: N.30, A.31, D.49, S.51, F.90
5 PLIP interactions:3 interactions with chain I, 2 interactions with chain N- Hydrophobic interactions: I:T.206
- Hydrogen bonds: I:N.64, I:K.67, N:D.49, N:S.51, N:S.51
NAG-NAG-BMA-MAN.30: 9 residues within 4Å:- Chain Q: N.107, I.108
- Chain S: Y.50, F.114, T.115, F.117
- Chain T: W.88, D.89, T.94
2 PLIP interactions:2 interactions with chain S- Hydrogen bonds: S:Y.50, S:T.115
NAG-NAG-BMA-MAN.38: 5 residues within 4Å:- Chain Q: N.355, S.357
- Ligands: NAG-NAG-BMA.37, NAG-NAG-BMA.37, NAG.53
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.41: 10 residues within 4Å:- Chain Q: N.64, K.67, T.206, E.245, N.246
- Chain V: N.30, A.31, D.49, S.51, F.90
5 PLIP interactions:3 interactions with chain Q, 2 interactions with chain V- Hydrophobic interactions: Q:T.206
- Hydrogen bonds: Q:N.64, Q:K.67, V:D.49, V:S.51, V:S.51
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.6: 7 residues within 4Å:- Chain C: P.182, N.232, N.346, G.348, V.414, S.415
- Ligands: NAG-NAG.12
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.20: 7 residues within 4Å:- Chain I: P.182, N.232, N.346, G.348, V.414, S.415
- Ligands: NAG-NAG.26
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.34: 7 residues within 4Å:- Chain Q: P.182, N.232, N.346, G.348, V.414, S.415
- Ligands: NAG-NAG.40
No protein-ligand interaction detected (PLIP)- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.9: 8 residues within 4Å:- Chain C: N.332, S.333, T.341, N.355, S.357
- Ligands: NAG-NAG-BMA-MAN.10, NAG-NAG-BMA-MAN.10, NAG.46
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.14: 6 residues within 4Å:- Chain B: T.18
- Chain C: N.58
- Chain D: G.55, I.56, T.57, F.70
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:I.56
- Hydrogen bonds: D:G.55, D:G.55
NAG-NAG-BMA.23: 8 residues within 4Å:- Chain I: N.332, S.333, T.341, N.355, S.357
- Ligands: NAG-NAG-BMA-MAN.24, NAG-NAG-BMA-MAN.24, NAG.49
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.28: 6 residues within 4Å:- Chain I: N.58
- Chain J: G.55, I.56, T.57, F.70
- Chain P: T.18
3 PLIP interactions:3 interactions with chain J- Hydrophobic interactions: J:I.56
- Hydrogen bonds: J:G.55, J:G.55
NAG-NAG-BMA.37: 8 residues within 4Å:- Chain Q: N.332, S.333, T.341, N.355, S.357
- Ligands: NAG-NAG-BMA-MAN.38, NAG-NAG-BMA-MAN.38, NAG.53
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.42: 6 residues within 4Å:- Chain Q: N.58
- Chain R: T.18
- Chain W: G.55, I.56, T.57, F.70
3 PLIP interactions:3 interactions with chain W- Hydrophobic interactions: W:I.56
- Hydrogen bonds: W:G.55, W:G.55
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.11: 17 residues within 4Å:- Chain C: T.267, R.296, H.299, N.301, S.381, T.383
- Chain E: R.103, I.104, G.106, V.107
- Chain F: S.24, N.44, N.45, N.46, P.60, G.61, S.62
4 PLIP interactions:2 interactions with chain E, 2 interactions with chain C- Hydrogen bonds: E:G.106, E:V.108, C:R.296, C:R.296
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.25: 17 residues within 4Å:- Chain I: T.267, R.296, H.299, N.301, S.381, T.383
- Chain L: R.103, I.104, G.106, V.107
- Chain M: S.24, N.44, N.45, N.46, P.60, G.61, S.62
4 PLIP interactions:2 interactions with chain L, 2 interactions with chain I- Hydrogen bonds: L:G.106, L:V.108, I:R.296, I:R.296
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.39: 17 residues within 4Å:- Chain Q: T.267, R.296, H.299, N.301, S.381, T.383
- Chain S: R.103, I.104, G.106, V.107
- Chain T: S.24, N.44, N.45, N.46, P.60, G.61, S.62
4 PLIP interactions:2 interactions with chain S, 2 interactions with chain Q- Hydrogen bonds: S:G.106, S:V.108, Q:R.296, Q:R.296
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.43: 3 residues within 4Å:- Chain B: E.123, N.126, Y.127
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:Y.127
NAG.44: 3 residues within 4Å:- Chain C: R.162, N.167
- Chain I: R.278
2 PLIP interactions:1 interactions with chain I, 1 interactions with chain C- Hydrogen bonds: I:R.278, C:R.162
NAG.45: 1 residues within 4Å:- Chain C: N.324
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.324
NAG.46: 5 residues within 4Å:- Chain C: S.357, N.361
- Ligands: NAG-NAG-BMA.9, NAG-NAG-BMA-MAN.10, NAG-NAG-BMA-MAN.10
No protein-ligand interaction detected (PLIP)NAG.47: 3 residues within 4Å:- Chain I: R.162, N.167
- Chain Q: R.278
2 PLIP interactions:1 interactions with chain I, 1 interactions with chain Q- Hydrogen bonds: I:R.162, Q:R.278
NAG.48: 1 residues within 4Å:- Chain I: N.324
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:N.324
NAG.49: 5 residues within 4Å:- Chain I: S.357, N.361
- Ligands: NAG-NAG-BMA.23, NAG-NAG-BMA-MAN.24, NAG-NAG-BMA-MAN.24
No protein-ligand interaction detected (PLIP)NAG.50: 3 residues within 4Å:- Chain P: E.123, N.126, Y.127
1 PLIP interactions:1 interactions with chain P- Hydrophobic interactions: P:Y.127
NAG.51: 3 residues within 4Å:- Chain C: R.278
- Chain Q: R.162, N.167
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain Q- Hydrogen bonds: C:R.278, Q:R.162
NAG.52: 1 residues within 4Å:- Chain Q: N.324
1 PLIP interactions:1 interactions with chain Q- Hydrogen bonds: Q:N.324
NAG.53: 5 residues within 4Å:- Chain Q: S.357, N.361
- Ligands: NAG-NAG-BMA.37, NAG-NAG-BMA-MAN.38, NAG-NAG-BMA-MAN.38
No protein-ligand interaction detected (PLIP)NAG.54: 3 residues within 4Å:- Chain R: E.123, N.126, Y.127
1 PLIP interactions:1 interactions with chain R- Hydrophobic interactions: R:Y.127
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kong, R. et al., Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization. Cell (2019)
- Release Date
- 2019-07-24
- Peptides
- A12V163-b.01 Light Chain: AKX
Envelope glycoprotein gp41: BPR
Envelope glycoprotein gp120: CIQ
A12V163-b.01 Heavy Chain: DJW
PGT122 Heavy chain: ELS
PGT122 Light chain: FMT
VRC03 heavy chain: GOU
VRC03 Light chain: HNV - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BK
4X
YB
UP
AR
DC
VI
2Q
CD
WJ
3W
XE
mL
5S
MF
nM
6T
NG
qO
8U
QH
rN
7V
R
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.20 Å
- Oligo State
- hetero-3-3-3-3-3-3-3-3-mer
- Ligands
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kong, R. et al., Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization. Cell (2019)
- Release Date
- 2019-07-24
- Peptides
- A12V163-b.01 Light Chain: AKX
Envelope glycoprotein gp41: BPR
Envelope glycoprotein gp120: CIQ
A12V163-b.01 Heavy Chain: DJW
PGT122 Heavy chain: ELS
PGT122 Light chain: FMT
VRC03 heavy chain: GOU
VRC03 Light chain: HNV - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BK
4X
YB
UP
AR
DC
VI
2Q
CD
WJ
3W
XE
mL
5S
MF
nM
6T
NG
qO
8U
QH
rN
7V
R